175 related articles for article (PubMed ID: 10423342)
1. Persistent effects of doxorubicin on cardiac gene expression.
Boucek RJ; Miracle A; Anderson M; Engelman R; Atkinson J; Dodd DA
J Mol Cell Cardiol; 1999 Aug; 31(8):1435-46. PubMed ID: 10423342
[TBL] [Abstract][Full Text] [Related]
2. Sarcoplasmic reticulum genes are selectively down-regulated in cardiomyopathy produced by doxorubicin in rabbits.
Arai M; Tomaru K; Takizawa T; Sekiguchi K; Yokoyama T; Suzuki T; Nagai R
J Mol Cell Cardiol; 1998 Feb; 30(2):243-54. PubMed ID: 9515001
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin-converting enzyme inhibitor on delayed-onset doxorubicin-induced cardiotoxicity.
Boucek RJ; Steele A; Miracle A; Atkinson J
Cardiovasc Toxicol; 2003; 3(4):319-29. PubMed ID: 14734829
[TBL] [Abstract][Full Text] [Related]
4. Impairment of the actin-myosin interaction in permeabilized cardiac trabeculae after chronic doxorubicin treatment.
Bottone AE; Voest EE; de Beer EL
Clin Cancer Res; 1998 Apr; 4(4):1031-7. PubMed ID: 9563899
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin and C-13 deoxydoxorubicin effects on ryanodine receptor gene expression.
Gambliel HA; Burke BE; Cusack BJ; Walsh GM; Zhang YL; Mushlin PS; Olson RD
Biochem Biophys Res Commun; 2002 Mar; 291(3):433-8. PubMed ID: 11855807
[TBL] [Abstract][Full Text] [Related]
6. Diminished molecular response to doxorubicin and loss of cardioprotective effect of dexrazoxane in Egr-1 deficient female mice.
Saadane N; Yue P; Alpert L; Mitmaker B; Kirby GM; Chalifour LE
Can J Physiol Pharmacol; 2001 Jun; 79(6):533-44. PubMed ID: 11430591
[TBL] [Abstract][Full Text] [Related]
7. Voluntary wheel running in rats receiving doxorubicin: effects on running activity and cardiac myosin heavy chain.
Hydock DS; Wonders KY; Schneider CM; Hayward R
Anticancer Res; 2009 Nov; 29(11):4401-7. PubMed ID: 20032385
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin represses CARP gene transcription through the generation of oxidative stress in neonatal rat cardiac myocytes: possible role of serine/threonine kinase-dependent pathways.
Aihara Y; Kurabayashi M; Tanaka T; Takeda SI; Tomaru K; Sekiguchi KI; Ohyama Y; Nagai R
J Mol Cell Cardiol; 2000 Aug; 32(8):1401-14. PubMed ID: 10900167
[TBL] [Abstract][Full Text] [Related]
9. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
Xu X; Sutak R; Richardson DR
Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
[TBL] [Abstract][Full Text] [Related]
10. Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model.
Aupperle H; Garbade J; Schubert A; Barten M; Dhein S; Schoon HA; Mohr FW
Vet Pathol; 2007 Jul; 44(4):494-503. PubMed ID: 17609194
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
Richard C; Ghibu S; Delemasure-Chalumeau S; Guilland JC; Des Rosiers C; Zeller M; Cottin Y; Rochette L; Vergely C
J Pharmacol Exp Ther; 2011 Dec; 339(3):807-14. PubMed ID: 21934029
[TBL] [Abstract][Full Text] [Related]
12. How to protect doxorubicin-induced cardiomyopathy in male albino rats?
Shaker O; Sourour DA
J Cardiovasc Pharmacol; 2010 Mar; 55(3):262-8. PubMed ID: 20051877
[TBL] [Abstract][Full Text] [Related]
13. Anthracyclines enhance tension development in cardiac muscle by direct interaction with the contractile system.
Bottone AE; de Beer EL; Voest EE
J Mol Cell Cardiol; 1997 Mar; 29(3):1001-8. PubMed ID: 9152861
[TBL] [Abstract][Full Text] [Related]
14. Protection against doxorubicin cardiomyopathy in rats: role of phosphodiesterase inhibitors type 4.
Mohamed HE; Asker ME; Ali SI; el-Fattah TM
J Pharm Pharmacol; 2004 Jun; 56(6):757-68. PubMed ID: 15231041
[TBL] [Abstract][Full Text] [Related]
15. Study on the effect of doxorubicin on expressions of genes encoding myocardial sarcoplasmic reticulum Ca2+ transport proteins and the effect of taurine on myocardial protection in rabbits.
Huang XM; Zhu WH; Kang ML
J Zhejiang Univ Sci; 2003; 4(1):114-20. PubMed ID: 12656353
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin impairs crossbridge turnover kinetics in skinned cardiac trabeculae after acute and chronic treatment.
de Beer EL; Bottone AE; van Der Velden J; Voest EE
Mol Pharmacol; 2000 Jun; 57(6):1152-7. PubMed ID: 10825385
[TBL] [Abstract][Full Text] [Related]
17. Thyroid hormone induced changes in cardiac proteins and mRNAs.
Dillmann WH; Rohrer D; Popovich B; Barrieux A
Horm Metab Res Suppl; 1987; 17():26-9. PubMed ID: 2895058
[TBL] [Abstract][Full Text] [Related]
18. Does the beta2-agonist clenbuterol help to maintain myocardial potential to recover during mechanical unloading?
Tsuneyoshi H; Oriyanhan W; Kanemitsu H; Shiina R; Nishina T; Matsuoka S; Ikeda T; Komeda M
Circulation; 2005 Aug; 112(9 Suppl):I51-6. PubMed ID: 16159865
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat.
Su X; Brower G; Janicki JS; Chen YF; Oparil S; Dell'Italia LJ
J Mol Cell Cardiol; 1999 Oct; 31(10):1927-36. PubMed ID: 10525429
[TBL] [Abstract][Full Text] [Related]
20. Dexrazoxane pre-treatment protects skinned rat cardiac trabeculae against delayed doxorubicin-induced impairment of crossbridge kinetics.
de Beer EL; Bottone AE; van Rijk MC; van der Velden J; Voest EE
Br J Pharmacol; 2002 Apr; 135(7):1707-14. PubMed ID: 11934811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
